Decreased monoamine metabolites in frontotemporal dementia and Alzheimer’s disease
- 1 September 1998
- journal article
- Published by Elsevier in Neurobiology of Aging
- Vol. 19 (5) , 379-384
- https://doi.org/10.1016/s0197-4580(98)00086-4
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Decreased Lumbar Cerebrospinal Fluid Levels of Monoamine Metabolites in Vascular DementiaInternational Psychogeriatrics, 1996
- Monoamine neurons in aging and Alzheimer's diseaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1993
- Protein Analyses in Cerebrospinal FluidEuropean Neurology, 1993
- Significance of decreased lumbar CSF levels of HVA and 5-HIAA in Alzheimer's diseaseNeurobiology of Aging, 1992
- Monoamine Metabolites in Cerebrospinal Fluid and Behavioral Ratings in Patients with Early and Late Onset of Alzheimer DementiaAlzheimer Disease & Associated Disorders, 1989
- Cerebrospinal fluid neurochemistry in the myoclonic subtype of Alzheimer's diseaseAnnals of Neurology, 1988
- Monoamines and their metabolites in cerebrospinal fluid of patients with senile dementia of Alzheimer type using high performance liquid chromatography and gas chromatography-mass spectrometryActa Psychiatrica Scandinavica, 1987
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- A new rating scale for dementia syndromesArchives of Gerontology and Geriatrics, 1982
- On the origin of homovanillic acid (HVA) in the cerebrospinal fluidJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1973